Back
Novartis AG Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
87
NVSEF
Novartis AG
Last Price:
104.00
Seasonality Move:
2.74%
Buy
55
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
45.13
Seasonality Move:
-11.02%
Buy
87
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVSEF] share price is $104.00. The Score for NVSEF is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- NVSEF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $45.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $104.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $45.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.25 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.24 - 104.02) | Buy |
Bollinger Bands (100): | (95.55 - 102.79) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 51.62 | Buy |
Chaikin Money Flow: | 1520753 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.2 - 48.24) | Buy |
Bollinger Bands (100): | (31.14 - 46.02) | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.92 | Buy |
20-day SMA: | 102.46 | Buy |
50-day SMA: | 99.61 | Buy |
200-day SMA: | 97.87 | Buy |
8-day EMA: | 103.61 | Buy |
20-day EMA: | 102.54 | Buy |
50-day EMA: | 100.68 | Buy |
200-day EMA: | 96.45 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.66 | Buy |
20-day SMA: | 45.82 | Sell |
50-day SMA: | 42.78 | Buy |
200-day SMA: | 22.9 | Buy |
8-day EMA: | 44.51 | Buy |
20-day EMA: | 44.85 | Buy |
50-day EMA: | 42.76 | Buy |
200-day EMA: | 28.27 | Buy |
Novartis AG Earnings Growth & NVSEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.70 per share, an increase next quarter of $0.13 per share, an increase this year of $5.96 per share, and an increase next year of $0.18 per share.
Novartis AG Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |